{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:57:56Z","timestamp":1792069076817,"version":"4.4.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>Postoperative nausea and vomiting (PONV) is one of the most common adverse effects of anesthesia and surgery, resulting in patient discomfort and dissatisfaction. Latest research has demonstrated the efficacy of NK-1 receptor antagonists in PONV management and its use in chemotherapy nausea prophylaxis. The authors of this article would like to provide evidence to support the use fosaprepitant, as monotherapy, in postoperative care, replacing a polypharmacological standard of care regimen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a retrospective chart review of 400 patients who received standard of care antiemetic regimen or received fosaprepitant (No-Fosaprepitant vs. Fosaprepitant groups, respectively). The primary outcome of this study is to evaluate the impact of fosaprepitant (administered intravenously) on perioperative antiemetic use, treatment cost, and patient satisfaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Total PONV medication cost decreased with the replacement of standard of care regimen for fosaprepitant, from 46.47\u00b120.54 United States Dollars in the no-Fosaprepitant group to 25.69\u00b114.84 United States Dollars in the Fosaprepitant group. There was a significant reduction in antiemetic doses between groups; 0.37\u00b10.745 versus 7.61\u00b15.202 for ondansetron (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.001), 92\u00b11.279 versus 2.21\u00b12.399 for promethazine (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.001), 0.25\u00b10.685 versus 1.41\u00b10.577 for scopolamine patch (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.001), and 0.05\u00b10.218 versus 1.14\u00b10.398 for dexamethasone (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.001). Patient satisfaction, measured by a questionnaire, was a 11.6% higher in the Fosaprepitant group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Fosaprepitant is a relevant alternative in preventing and treating PONV in patients who underwent bariatric\/metabolic surgical procedures.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sle.0000000000001101","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T15:00:06Z","timestamp":1677164406000},"page":"265-269","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Impact of Emend on Perioperative Bariatric Surgery Antiemetic Utilization, Patient Satisfaction, and Costs"],"prefix":"10.1097","volume":"33","author":[{"given":"Gary S.","family":"Aghazarian","sequence":"first","affiliation":[{"name":"Department of Bariatric Surgery, 89 W Copeland Dr, 1st Floor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romulo","family":"Lind","sequence":"additional","affiliation":[{"name":"Department of Bariatric Surgery, 89 W Copeland Dr, 1st Floor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Motola","sequence":"additional","affiliation":[{"name":"Department of Bariatric Surgery, 89 W Copeland Dr, 1st Floor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Perry","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Orlando Regional Medical Center, Orlando Health, 1414 Kuhl Ave., Orlando, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Singletary","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Orlando Regional Medical Center, Orlando Health, 1414 Kuhl Ave., Orlando, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Lastrapes","sequence":"additional","affiliation":[{"name":"Department of Bariatric Surgery, 89 W Copeland Dr, 1st Floor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Department of Bariatric Surgery, 89 W Copeland Dr, 1st Floor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad A.","family":"Jawad","sequence":"additional","affiliation":[{"name":"Department of Bariatric Surgery, 89 W Copeland Dr, 1st Floor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Department of Bariatric Surgery, 89 W Copeland Dr, 1st Floor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"R1-20250817","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/aas.12884","article-title":"Post-operative nausea and vomiting in bariatric surgery patients: an observational study","volume":"61","author":"Halliday","year":"2017","journal-title":"Acta Anaesthesiol Scand"},{"key":"R2-20250817","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00004311-200341040-00012","article-title":"Post-operative nausea and vomiting and outcome","volume":"41","author":"Scuderi","year":"2003","journal-title":"Int Anesthesiol Clin"},{"key":"R3-20250817","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.21832.1","article-title":"Management strategies for the treatment and prevention of postoperative\/postdischarge nausea and vomiting: an updated review","volume":"9","author":"Elvir-Lazo","year":"2020","journal-title":"F1000Res"},{"key":"R4-20250817","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2147\/TCRM.S256234","article-title":"Prevention and Treatment of Postoperative Nausea and Vomiting (PONV): A Review of Current Recommendations and Emerging Therapies","volume":"16","author":"Jin","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"R5-20250817","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11695-013-1065-1","article-title":"Aprepitant\u2019s prophylactic efficacy in decreasing post-operative nausea and vomiting in morbidly obese patients undergoing bariatric surgery","volume":"24","author":"Sinha","year":"2014","journal-title":"Obes Surg"},{"key":"R6-20250817","doi-asserted-by":"crossref","first-page":"307025","DOI":"10.1155\/2014\/307025","article-title":"The effects of intravenous fosaprepitant and ondansetron for the prevention of postoperative nausea and vomiting in neurosurgery patients: a prospective, randomized, double-blinded study","volume":"2014","author":"Tsutsumi","year":"2014","journal-title":"Biomed Res Int"},{"key":"R7-20250817","first-page":"CD012859","article-title":"Drugs for preventing ost-operative nausea and vomiting in adults after general anaesthesia: a network meta-analysis","volume":"10","author":"Weibel","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250817","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00268-016-3492-3","article-title":"Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations","volume":"40","author":"Thorell","year":"2016","journal-title":"World J Surg"},{"key":"R9-20250817","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12955-017-0610-3","article-title":"Psychometric properties of the Press Ganey Outpatient Medical Practice Survey","volume":"15","author":"Presson","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"R11-20250817","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11695-017-2797-0","article-title":"The role of aprepitant in prevention of post-operative nausea and vomiting after bariatric surgery","volume":"28","author":"Therneau","year":"2018","journal-title":"Obes Sur"},{"key":"R12-20250817","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1100\/tsw.2009.34","article-title":"Aprepitant in a multimodal approach for prevention of postoperative nausea and vomiting in high-risk patients: is there such a thing as \u201ctoo many modalities\u201d?","volume":"9","author":"Hache","year":"2009","journal-title":"Sci World J"}],"container-title":["Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLE.0000000000001101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:00:22Z","timestamp":1755446422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLE.0000000000001101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,20]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/sle.0000000000001101","relation":{},"ISSN":["1534-4908"],"issn-type":[{"value":"1534-4908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,20]]},"assertion":[{"value":"2022-01-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}